Sveriges mest populära poddar
Start / PharmaTalkRadio / Innovations in manufacturing to make car t more accessible and affordable

PharmaTalkRadio

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

20 min • 25 juli 2025
Summary:
Accessibility to CAR-T is limited by traditional manufacturing, with its associated challenges and high cost. Moffitt Cancer Center's Chief BioEngineering Officer, Dr Greg Sawyer, highlights Moffitt's significant progress in enhancing T cell potency and boosting efficacy through engineering strategies. Dr Sawyer discusses assays enabling precise asessment of T cell potency, developments in manufacturing, and more, and the resulting impact on scalability and efficiency. 

This presentation comes from the March 2025 Immuno-Oncology 360º Summit. For more information, go to IO360summit.com. 

Senaste avsnitt

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

14 augusti | 29 min

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

12 augusti | 28 min

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

12 augusti | 28 min

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min
Vad är en podd?

En liten tjänst av I'm With Friends. Finns även på engelska.

Podcastbild

00:00 -00:00
00:00 -00:00